Experience
Horizon Pharma
Dr. Reddy's Laboratories
Counsel for Horizon in Hatch-Waxman patent infringement litigations against several companies seeking to market generic copies of Vimovo®. District court ruled in favor of Horizon, and appeal now pending.
Horizon Pharma v. Dr. Reddy's Laboratories, 3:11-cv-02317, 3:11-cv-04275, 3:13-cv-00091, 3:13-cv-04022, D.N.J., Judge Cooper
Horizon Pharma v. Dr. Reddy's Laboratories, 17-2473, -2481, -2484, -2486, -2487, -2488, -2489, -2491, -2491, -2493, Fed. Cir.
Pozen Inc. v. Dr. Reddy’s Laboratories Inc.
Horizon Medicines LLC
Bausch & Lomb Incorporated et al
Abbott Laboratories v. Teva Pharmaceuticals USA, Inc.
Abbott Laboratories
AstraZeneca LP v. SigmaPharm Laboratories
AstraZeneca LP
Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al.
Duchesnay Inc.
Eli Lilly and Company v. Actavis Labs. UT Inc.
Eli Lilly and Company
Sequenom, Inc. et al
Otsuka Pharmaceutical Co., Ltd. v. Apotex Corp.
Otsuka Pharmaceutical Co., Ltd.
Bausch Health Ireland Limited et al. v. Lupin Limited et al.
Bausch Health Ireland Limited et al.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.